MedTrace Logo

Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer

NCT01300104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2015-02-19

No results posted yet for this study

Summary

PURPOSE:

To evaluate the feasibility of a future Nordic intervention trial, including vigorous activity and a high intake of whole grain rye, among prostate cancer patients on active surveillance.

Additionally, to investigate effects of the lifestyle intervention according to cancer progression, the metabolic profile, inflammation and quality of life among prostate cancer patients on active surveillance.

Conditions

Interventions

BEHAVIORAL

Exercise

Prescriptions: Vigorous exercise (average 65-70% of maximal oxygen consumption) minimum 3 times 45 minutes per week according to customized endurance training programs. Restrictions: None.

BEHAVIORAL

Whole grain rye

Prescriptions: Minimum 170-180g of whole grain rye intake per day. Restrictions: None.

BEHAVIORAL

Recommendations

Recommendations on a health-promoting, energy restricted diet according to Danish Nutrition Recommendations and encouraged to walk at least 10,000 steps every day.

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • University of Aarhus

    collaborator OTHER

  • European Commission

    collaborator OTHER

  • Danish Cancer Society

    lead OTHER

Principal Investigators

  • Anne Tjønneland, Dr.Med.Sci. · Danish Cancer Society Research Center

  • Rikke D Hansen, Dr. · Danish Cancer Society Research Center

  • Michael Borre, Prof. · Aarhus University Hospital Skejby

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01300104 on ClinicalTrials.gov